Climate change is expanding disease zones, and innovative tools are now available to help doctors monitor and prevent climate ...

The Swiss pharma group says it has earmarked $100 million for new treatments for Chagas disease, leishmaniasis, dengue fever and cryptosporidiosis, with $150 million going towards new antimalarial ...